![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
How McKesson Uses Predictive Analytics to Help Health Systems Identify Drug Profitability
The UA tool provides insights that allow customers to understand the impact of their formulary and purchasing decisions.
By
Date
March 07, 2023
Read time: 4 minutes
By: Nicole Mayo
Understanding Predictive Analytics
The increased adoption of electronic health records has improved the way in which patient information is collected and stored. The resulting volume of generated patient data has prompted healthcare entities to invest in tools which analyze patient data and provide actionable insights.
According to a BBC Research report1, hospitals spent an estimated $6.2 billion on analytics resources in 2017. This number was expected to soar to $14.9 billion by close of 2022.
Hospitals have begun identifying links between disease states, social determinants of health, and drug therapies and missed appointments, utilization of medical services, and readmission rates. Armed with these insights, they are addressing these gaps by incorporating additional support and resources where needed most.
By targeting specific outcomes and examining historic data, predictive analytics allows stakeholders to identify patterns and commonalities across data points. Stakeholders can then proactively devise strategies to minimize the recurrence of those future events.
Health system pharmacies deploy similar predictive analytics methods to alter drug procurement patterns, render formulary decisions, and establish pharmacy budgets.
Predictive Analytics Moving Forward
Health systems are now leveraging all available insights to make better informed decisions. Algorithms and predictive analytics allow for more proactive decision-making and drive sustainability strategies. By examining historic trends and fluctuations in drug utilization, procurement teams can establish analytically sound strategies to avoid over- or under-purchasing drugs. In addition, health care entities will be able to see the value in understanding how drugs are being reimbursed and why this is important when making formulary decisions and establishing best practices.
With the increase of new drug therapies and biosimilar agents, health system pharmacies are shifting their cost containment strategies and investing more resources into tools that will streamline the decision-making process.
How McKesson Uses Predictive Analytics to Help Customers
Data insights within the Utilization Analytics (UA) tool allow health system customers to fully understand the impact of their formulary and purchasing decisions while equipping them to have larger conversations with multidisciplinary teams outside of pharmacy.
Through the incorporation of assumptions within the analysis, UA customers can examine scenarios on a more granular level. Understanding the implications of payer distribution, site of care nuances, and fluctuating reimbursement rates allows UA users to conduct predictive profitability analysis and identify drug profit margins.
Click to learn how McKesson’s Utilization Analytics can help your health system achieve more while enhancing visibility into the financial performance of your health system pharmacy.
Expect more from your distributor. Achieve more with McKesson.
1BCC Research LLC. (Nov 2017). Healthcare analytics: Technologies and global markets.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.
The top three Prescribed Perspectives articles downloaded by health systems in June.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.